Andrew Callos, EVP, Chief Commercial Officer at CYTOKINETICS INC (CYTK), sold 26,000 shares at $61.87 ($1.6M) on 2026-03-05, disclosed to the SEC on 2026-03-05.
Seasonal sale ($1.6M) by EVP, Chief Commercial Officer — this insider has traded CYTK in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.87 | 15,000 | $928K | 57.7% |
| 2 | $61.88 | 11,000 | $681K | 42.3% |
| Total | $61.87 avg | 26,000 | $1.6M | 100% |
| Filing → |
| CYTK | SELL | 2026-07-02 | $1.3M | — | Filing → |
| CYTK | SELL | 2026-06-01 | $1.1M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $875K | — | Filing → |